Form 4 for FDMT 4D Molecular Therapeutics, Inc.
Accepted 2025-12-16 00:00:00 ET · period of report 2025-12-12 · accession 0001193125-25-320992 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-16 | 2025-12-12 | FDMT | THEUER CHARLES | Dir | M - OptEx | $1.14 | +9,333 | 41.7K | +29% | +$10.6K |
| D | 2025-12-16 | 2025-12-12 | FDMT | THEUER CHARLES | Dir | M - OptEx | $0.00 | -9,333 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-12 | M | A | 9,333 | $1.14 | 41,684 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-12-12 | M | D | 9,333 | $0.00 | 0 | D | $1.14 · — to 2026-03-09 | 9,333 Common Stock | (F1) Fully vested. |